Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

Zylem Biosciences, a company specializing in cancer and cardiovascular therapeutics, announced that Northwestern University ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Learn how the chemical synthesis method for mRNA can accelerate vaccine production, enhancing responses to viral outbreaks ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...